Scienture Holdings Inc (SCNX)

Nov 11, 2024

Walgreens Boots Alliance (WBA) Stock Surges Amid Market Activity - GuruFocus.com

Nov 11, 2024

Nov 06, 2024

Scienture Holdings: Q3 Earnings Snapshot - CTPost

Nov 06, 2024

Nov 06, 2024

White Mountains: Q3 Earnings Snapshot - AOL

Nov 06, 2024

Oct 12, 2024

Scienture completes preferred stock conversion By Investing.com - Investing.com Australia

Oct 12, 2024

Oct 11, 2024

Scienture completes preferred stock conversion - Investing.com India

Oct 11, 2024

Oct 11, 2024

Scienture : Material Event Form 8 K - Marketscreener.com

Oct 11, 2024

Oct 08, 2024

Scienture Holdings Shares Insight with Investor Presentation - TipRanks

Oct 08, 2024

Oct 06, 2024

Gajan A. Mahendiran and Amudha Mahendiran acquired Westminster Pharmaceutical LLC from Trxade Group, Inc. for $1.6 million. - Marketscreener.com

Oct 06, 2024

Oct 04, 2024

Top Premarket Gainers - Marketscreener.com

Oct 04, 2024

Sep 24, 2024

Scienture Holdings Unveils New Identity Post-Merger - TipRanks

Sep 24, 2024

Sep 24, 2024

TRxADE Health changes its name to Scienture Holdings - AlphaStreet

Sep 24, 2024

Sep 24, 2024

Bats Reveal Superior Adaptation to Endure Heart Stress: National Heart Centre Singapore Partners Paratus Sciences Singapore to Accelerate Heart Failure Care - ForexTV.com

Sep 24, 2024

Sep 24, 2024

Nectero Medical Recognized as a 2024 AZBio Fast Lane Award Winner - ForexTV.com

Sep 24, 2024

Sep 24, 2024

TRxADE Health rebrands as Scienture Holdings with new ticker SCNX - Investing.com

Sep 24, 2024

Sep 24, 2024

TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. and Ticker Symbol Change to “SCNX” - Morningstar

Sep 24, 2024

Sep 24, 2024

SCNXScienture Holdings, Inc. Latest Stock News & Market Updates - StockTitan

Sep 24, 2024

Sep 20, 2024

TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. - ForexTV.com

Sep 20, 2024

Sep 20, 2024

Trxade Health announces name change to Scienture Holdings - TipRanks

Sep 20, 2024

Sep 17, 2024

Guardian Pharmacy seeks to raise up to $108 mil in US IPO - AlphaStreet

Sep 17, 2024

Aug 27, 2024

Everything you need to know about Zenas BioPharma’s IPO - AlphaStreet

Aug 27, 2024

Jul 31, 2024

Trxade Group’s Strategic Merger and Rebranding as Scienture Holdings - TipRanks

Jul 31, 2024

Jul 29, 2024

TRxADE HEALTH completes all-stock merger deal with Scienture - World Pharmaceutical Frontiers

Jul 29, 2024

Jul 26, 2024

Trxade Health closes business combination with Scienture in $103Mln deal - AlphaStreet

Jul 26, 2024

Jul 22, 2024

Envoy Medical is well-positioned to gain market share in hearing implant space: CEO - AlphaStreet

Jul 22, 2024

Jul 10, 2024

AgEagle’s latest focus is on tailoring products for defense, public safety industries: CEO - AlphaStreet

Jul 10, 2024

Jul 03, 2024

Everything you need to know about OS Therapies’ upcoming IPO - AlphaStreet

Jul 03, 2024

Jun 28, 2024

MEDS Earnings: Highlights of Trxade Health’s Q1 2024 financial results - AlphaStreet

Jun 28, 2024

Jun 27, 2024

TRxADE Health, Inc. Files its Q1 10-Q; Reporting Positive Net Income Due to Asset Sale - StockTitan

Jun 27, 2024

Jun 25, 2024

Alumis looks to raise $300 million in IPO. Here’s what you need to know - AlphaStreet

Jun 25, 2024

Jun 06, 2024

Tempus AI gears up for IPO. Here’s everything you need to know - AlphaStreet

Jun 06, 2024

May 10, 2024

Trxade Health Inc. (NASDAQ: MEDS) Q1 2024 Research Summary - AlphaStreet

May 10, 2024

Apr 04, 2024

Femasys is committed to providing women with revolutionary healthcare products: CEO - AlphaStreet

Apr 04, 2024

Mar 06, 2024

Trxade Health, Inc. Announces Special Cash Dividend, Payable on or About March 22, 2024 - Marketscreener.com

Mar 06, 2024

Feb 12, 2024

Trxade Health Inc. (NASDAQ: MEDS) Q4 2023 Research Summary - AlphaStreet

Feb 12, 2024

Jan 17, 2024

MEDS Earnings: A snapshot of Trxade Health’s Q3 2023 financial results - AlphaStreet

Jan 17, 2024

Jan 16, 2024

TRxADE: Q3 Earnings Snapshot - Marketscreener.com

Jan 16, 2024

Dec 10, 2023

Nordic Group makes another acquisition to diversify earnings base - Yahoo Finance

Dec 10, 2023

Nov 09, 2023

Trxade Health Inc. (NASDAQ: MEDS) Q3 2023 Research Summary - AlphaStreet

Nov 09, 2023

Sep 29, 2023

Petros Pharma is focused on establishing mechanisms for Rx-to-OTC switch: CCO Fady Boctor - AlphaStreet

Sep 29, 2023

Sep 04, 2023

symbol__ Stock Quote Price and Forecast - CNN

Sep 04, 2023

Apr 11, 2023

Continued focus on core B2B segment drives new business: Trxade CEO Suren Ajjarapu - AlphaStreet

Apr 11, 2023

Mar 29, 2023

TC BioPharm develops safer, less expensive products to target more cancers: CEO Bryan Kobel - AlphaStreet

Mar 29, 2023

Mar 27, 2023

Earnings: Trxade Health (MEDS) reports 16% rise in FY22 revenue; loss narrows - AlphaStreet

Mar 27, 2023

Mar 03, 2023

TRxADE HEALTH, Inc. Announces Janet Huffman, the Chief Financial Officer Terminate Her Offer Letter and Transitioned from Chief Financial Officer to Acting Chief Financial Officer - Marketscreener.com

Mar 03, 2023

Feb 23, 2023

Current initiatives should enable Flux Power to reach profitability: CEO Ron Dutt - AlphaStreet

Feb 23, 2023

Dec 19, 2022

Trxade Health Inc. (NASDAQ: MEDS) Q4 2022 Research Summary - AlphaStreet

Dec 19, 2022

May 23, 2022

Trxade (MEDS) is increasing the breadth of product offerings: CEO Suren Ajjarapu - AlphaStreet

May 23, 2022

Oct 29, 2021

Trxade CEO Suren Ajjarapu: Will see the impact of GPO program by Q3 next year - AlphaStreet

Oct 29, 2021

Oct 26, 2021

Trxade Health beats on Q3 revenue estimate - AlphaStreet

Oct 26, 2021

Jul 12, 2021

IPO News: Here’s what to know when Sera Prognostics goes public this week - AlphaStreet

Jul 12, 2021

Sep 03, 2020

MEDSTRxADE HEALTH, Inc. Latest Stock News & Market Updates - StockTitan

Sep 03, 2020

Jul 29, 2020

No concerns on margin side: Trxade (MEDS) CEO Suren Ajjarapu - AlphaStreet

Jul 29, 2020

Feb 17, 2020

MEDS Stock Price and Chart — NASDAQ:MEDS - TradingView

Feb 17, 2020

Dec 23, 2014

Trxade Group, Inc. Elects Donald Almeida to Board of Directors - Marketscreener.com

Dec 23, 2014